ScanSource to buy MicroAge for $220.5 million as Q4 net sales rose 17.3%
On August 19, 2026, ScanSource agreed to acquire MicroAge, a technology provider, for $220.5 million in cash at closing, with closing expected in September 2026 subject to antitrust waiting-period expiration and third-party consents. On August 20, the company reported fourth-quarter fiscal 2026 net sales of $953.1 million, up 17.3%, and GAAP diluted EPS of $1.24 versus $0.88, and issued fiscal 2027 guidance that excludes the pending MicroAge deal.
Key points
- Purchase price is $220.5 million in cash at closing, with $3 million in escrow for purchase price adjustments and $6.8 million for indemnification claims.
- Q4 fiscal 2026 (quarter ended June 30, 2026): net sales $953.1 million, up 17.3%; GAAP diluted EPS $1.24 versus $0.88 a year earlier.
- Fiscal 2026 GAAP net income was $78.9 million, or $3.64 per diluted share, versus $3.00; cash was $88.4 million and total debt was $101.4 million at June 30, 2026.
- Fiscal 2027 outlook (excluding MicroAge): net sales growth of 6% to 10%, adjusted EBITDA of $158 million to $165 million, and free cash flow of at least $85 million.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 6:59 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 20, 2026.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.